Bioprocessing technology market seen reaching $139.77B by 2030

By AI, Created 2:23 PM UTC, June 03, 2026, /AGP/ – The Business Research Company says the global bioprocessing technology market is on track to grow from $71.39 billion in 2025 to $139.77 billion by 2030, driven by biologics manufacturing, automation and chronic disease demand. North America led the market in 2025, while new report features focus on TAM analysis, forecasting dashboards and trend tracking.

Why it matters: - Bioprocessing technology supports the production of biologics, vaccines, diagnostic tools, foods, fuels and other products tied to health and industrial supply chains. - Faster market growth signals rising demand for manufacturing capacity, process automation and scalable production in life sciences. - Chronic disease growth is expanding the need for therapies and diagnostics that depend on bioprocessing.

What happened: - The Business Research Company projected the global bioprocessing technology market will rise from $71.39 billion in 2025 to $81.45 billion in 2026. - The company forecast the market will reach $139.77 billion by 2030. - The 2026 to 2030 forecast implies a 14.5% compound annual growth rate. - The report was issued June 3, 2026, from London. - The company offered a free sample of the report and a full market report.

The details: - Market growth in 2025-26 was tied to biologics manufacturing demand, higher biopharmaceutical production capacity, wider use of cell culture technologies, more life sciences research spending and better access to bioprocessing consumables. - Growth through 2030 is expected to come from demand for biosimilars and recombinant proteins, greater automation in biomanufacturing, more personalized medicine production, process optimization efforts and higher outsourcing to contract manufacturing organizations. - Key trends identified in the market include single-use bioprocessing systems, automated cell expansion platforms, advanced biologics safety testing, continuous bioprocessing and scalable manufacturing techniques. - Bioprocessing technology uses microbes, living cells or parts of living organisms to make biological products. - The technology is used in chemicals, food ingredients, flavors, fuels and pharmaceuticals. - Enzymes and microorganisms often serve as biocatalysts in these production processes. - The report adds market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables. - Related reports cited by the company include Bioprocess Technology Global Market Report 2026, Single Use Bioprocessing Global Market Report 2026, and Large And Small Scale Bioprocessing Global Market Report 2026.

Between the lines: - The forecast suggests bioprocessing is becoming a core enabling layer for biologics and personalized medicine manufacturing. - North America led the market in 2025, which points to a mature industrial base and strong life sciences investment in the region. - The focus on CMOs and automation suggests manufacturers are pushing for lower cost, faster scale-up and more flexible production. - The World Health Organization projected in February 2024 that new cancer cases could exceed 35 million by 2050, up 77% from about 20 million in 2022, underscoring the long-term demand backdrop for therapeutic production.

What’s next: - Adoption of single-use systems and continuous bioprocessing is likely to widen as manufacturers chase efficiency and scalability. - Automation and advanced testing tools should gain more traction as biomanufacturers expand capacity and tighten quality requirements. - The company’s report set out coverage across North America, Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

The bottom line: - Bioprocessing technology is moving from a specialized manufacturing tool to a larger strategic market shaped by therapy demand, automation and global scale-up needs.